Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Safety and efficacy of mitoxantrone in pediatric patients with aggressive multiple sclerosis.
Novel MS Drug Offers Good Functional Outcomes
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis.
Interferon β for secondary progressive multiple sclerosis: a systematic review.
Alemtuzumab and multiple sclerosis: therapeutic application.
Safety Study of Interferon Beta-1a for Acute Stroke
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
The potential teratogenic effects of interferon beta-1a (IFNβ-1a) and interferon beta-1b (IFNβ-1b) on in vitro embryonic development.
Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA
Genzyme's Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis
Pericytes are required for blood-brain barrier integrity during embryogenesis.
Keystone Symposium: Advances in the Knowledge and Treatment of Autoimmunity
Glatiramer acetate, an anti-demyelination drug, reduced rats' epileptic seizures induced by pentylenetetrazol via protection of myelin sheath.
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
A genetic screen identifies genes essential for development of myelinated axons in zebrafish.
Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis.
Interferon beta for secondary progressive multiple sclerosis.
Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™).
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
Placebo-controlled trial of oral laquinimod for multiple sclerosis.
A full genome search in multiple sclerosis.
Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR.
Pages
« first
‹ previous
…
105
106
107
108
109
110
111
112
113
…
next ›
last »